换一批
换一批Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World
摘要To the Editor:Current treatment guidelines for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) recommend dual antiplatelet therapy,a combination of aspirin and a P2Y12 inhibitor (i.e.,clopidogrel,prasugrel,and ticagrelor) for a minimum of 12 months.
更多相关知识
栏目名称
Correspondence
DOI
10.4103/0366-6999.244106
发布时间
2018-12-07
- 浏览11
- 被引7
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
